Leprosy Active Searching Trial in Brazil
NCT06761469 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1925
Last updated 2026-04-28
Summary
The goal of this clinical trial is to assess whether a multifactorial active case-finding strategy improves the detection of leprosy cases in Brazil compared to usual screening practices. The main questions it aims to answer are:
\- Does the intervention increase the number of new leprosy cases detected compared to standard care?
Participants will:
* Receive community awareness about leprosy.
* Be screened using the Leprosy Suspicion Questionnaire at priority areas identified by georeference tools.
* Undergo clinical evaluation by a trained medical team.
* If leprosy is diagnosed, affected patients will collect complementary laboratory exams
Healthcare professionals from primary care units will receive training in leprosy, while researchers will monitor changes in leprosy incidence over a 12-month period using data from Brazil's national notification system. The study will provide insights into underdiagnosis and the clinical profiles of patients who have been diagnosed.
Conditions
- Leprosy
Interventions
- OTHER
-
Implementing active-case finding strategies
Implementation of a multifactorial active-case finding strategy, including: (1) raising awareness among the population about leprosy; (2) theoretical and practical educational training for healthcare workers; (3) georeferencing of historical and existing cases in the municipality (from 2012 to 2023) and of new cases diagnosed throughout the study (dynamic changes); (4) screening tools for signs/symptoms of the disease (application of Leprosy Suspicion Questionnaire); and (5) serological profile (rapid test) of patients with reported signs/symptoms (positive answers Leprosy Suspicion Questionnaire).
Sponsors & Collaborators
-
Hospital Alemão Oswaldo Cruz
lead OTHER
Principal Investigators
-
Rosa C Lucchetta, PhD · Hospital Alemão Oswaldo Cruz
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-06-01
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- Brazil
Study Locations
More Related Trials
-
Molecular Epidemiology of Leprosy - Philippines
NCT00315809 ·Status: COMPLETED
-
Complex Cutaneous Leishmaniasis Healing Study in Algeria
NCT03292835 ·Status: TERMINATED
-
Leprosy Skin Test Antigens Phase 1
NCT01920750 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil
NCT01359358 ·Status: UNKNOWN
-
Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia
NCT04699383 ·Status: COMPLETED
-
Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
NCT01138956 ·Status: UNKNOWN ·Phase: NA
-
Asymptomatic Leishmania Infection in HIV Patients
NCT02839603 ·Status: TERMINATED
-
Staphylococcus Aureus Resistant to Methicillin (MRSA) Screening in Trauma
NCT02842710 ·Status: WITHDRAWN ·Phase: NA
-
S. Aureus, Skin and Soft Tissue Infections
NCT02796742 ·Status: COMPLETED
-
Epidemiology of Leprosy in French Guiana
NCT05031091 ·Status: UNKNOWN
-
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
NCT03662022 ·Status: COMPLETED ·Phase: PHASE3
-
Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
NCT02281643 ·Status: COMPLETED ·Phase: PHASE2
-
Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia
NCT06695143 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
NCT05597280 ·Status: RECRUITING ·Phase: PHASE3
-
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3
-
Testing Hypersensitivity to Metals in Sarcoidosis Patients by Applying the MELISA Test.
NCT01809145 ·Status: UNKNOWN ·Phase: NA
-
Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
NCT00773864 ·Status: UNKNOWN
-
A Multicentre, Retrospective Study of Clinical Characteristics and Long-term Outcomes of Patients With Brucellosis
NCT06007326 ·Status: COMPLETED
-
Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
NCT04677543 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen
NCT00633009 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
NCT01498419 ·Status: COMPLETED ·Phase: PHASE2
-
Staphylococcus Aureus Nasal Carriage
NCT02796690 ·Status: COMPLETED
-
Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection
NCT00401557 ·Status: COMPLETED
-
BTZ-043 Dose Evaluation in Combination and Selection
NCT05926466 ·Status: RECRUITING ·Phase: PHASE2
-
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
NCT03338621 ·Status: COMPLETED ·Phase: PHASE2/PHASE3